Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation
- 1 March 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 38 (S2) , S112-S114
- https://doi.org/10.1007/bf01409477
Abstract
Summary The effects of labetalol and carvedilol on local cutaneous microvascular perfusion and calculated local cutaneous microvascular resistance were investigated in anesthetized rats at submaximal doses that produced equivalent reductions in blood pressure and heart rate. Labetalol decreased cutaneous perfusion (− 25% ± 3%) without significantly affecting cutaneous vascular resistance ( − 6% ± 3%). In marked contrast, carvedilol dramatically increased cutaneous perfusion ( + 64% ± 9%) and significantly reduced cutaneous vascular resistance ( − 57% ± 3%). These results suggest that carvedilol and labetalol possess differences in the mechanisms by which they produce vasodilation in vivo.Keywords
This publication has 8 references indexed in Scilit:
- Vascular Effects of Carvedilol, a New β-Adrenoceptor Antagonist with Vasodilating Properties, in Isolated Canine Coronary ArteryJournal of Cardiovascular Pharmacology, 1989
- In vitro Pharmacologic Profile of the Novel Beta-Adrenoceptor Antagonist and Vasodilator, CarvedilolPharmacology, 1989
- Pharmacological Profile of Carvedilol as a β-Blocking Agent with Vasodilating and Hypotensive PropertiesJournal of Cardiovascular Pharmacology, 1987
- Studies on the mode of vasodilating action of carvedilol.1987
- Antihypertensive compounds with combined actions.1987
- A new molecule with vasodilating and beta-adrenoceptor blocking properties.1987
- Antihypertensive Compounds with Combined ActionsJournal of Cardiovascular Pharmacology, 1987
- Laser doppler measurements of blood flow in skin tissueJournal of Biomedical Engineering, 1985